BECKER MUSCULAR DYSTROPHY
Clinical trials for BECKER MUSCULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new BECKER MUSCULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for BECKER MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Muscular dystrophy patients continue experimental treatment in Long-Term safety study
Disease control ENROLLING_BY_INVITATIONThis study continues testing an experimental drug called sevasemten (EDG-5506) in people with Becker muscular dystrophy to see how safe it is over the long term. It's open to 260 adults and adolescents who have already participated in earlier studies of this same medication. Rese…
Matched conditions: BECKER MUSCULAR DYSTROPHY
Phase: PHASE2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated Apr 02, 2026 03:56 UTC
-
New drug trial aims to slow muscle decline in genetic disorder
Disease control OngoingThis study is testing whether an investigational drug called sevasemten (EDG-5506) is safe and can help control the progression of Becker muscular dystrophy. It involves about 244 adults and adolescents with the condition, who will receive either the drug or a placebo for 12 to 1…
Matched conditions: BECKER MUSCULAR DYSTROPHY
Phase: PHASE2 • Sponsor: Edgewise Therapeutics, Inc. • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC